Nanobiotix S.A. ADR (NBTX) Social Stream
NANOBIOTIX SA (NBTX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NANOBIOTIX SA.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-17 | 1 | $26 | $26 | $26 | $7.68 | 238.54% |
| 2022-04-07 | 1 | $13.5 | $13.5 | $13.5 | $7.68 | 75.78% |
| 2022-08-10 | 1 | $8.5 | $8.5 | $8.5 | $7.68 | 10.68% |
| 2023-08-25 | 1 | $14.1 | $14.1 | $14.1 | $7.68 | 83.59% |
| 2023-09-27 | 1 | $13.8 | $13.8 | $13.8 | $7.68 | 79.69% |
| 2023-10-06 | 1 | $13.1 | $13.1 | $13.1 | $7.68 | 70.57% |
| 2023-12-08 | 2 | $13.1 | $11 | $12.05 | $7.68 | 56.9% |
| 2023-12-14 | 2 | $12.9 | $11 | $11.95 | $7.68 | 55.6% |
| NA | 1 | $NA | $NA | $NA | $7.68 | NA% |
Price Target Last Issued October 6, 2023
Over the past 111 days, NBTX's average upside potential has been 83.06%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-09-27 | 1 | 13.8 | 13.8 | 13.80 | 8.105 | 70.27% |
| 2023-10-06 | 1 | 13.1 | 13.1 | 13.10 | 6.720 | 94.94% |
| 2023-10-06 | 2 | 13.1 | 13.1 | 13.10 | 6.720 | 94.94% |
| 2023-12-08 | 2 | 13.1 | 11.0 | 12.05 | 5.735 | 110.11% |
| 2023-12-14 | 2 | 12.9 | 11.0 | 11.95 | 6.105 | 95.74% |
NBTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 16 months, NBTX's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, NANOBIOTIX SA's number of analysts covering the stock is greater than 11.28% of them.
- In terms of how NANOBIOTIX SA fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than 84.68% of that group.
- In terms of how NANOBIOTIX SA fares relative to Healthcare stocks, note that its average analyst price target is greater than 262.64% of that group.
- In terms of how NANOBIOTIX SA fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 421.18% of that group.
Stocks similar to NANOBIOTIX SA in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PHAR, GRCL, and EFTR.
View All Top Stocks by Price Target
Is NBTX a Buy, Hold or Sell? See the POWR Ratings now!